Tag: mammogram

Articles

• Ductal carcinoma in situ (DCIS) prognosis
• Screening mammograms should start at age 40
• Young breast cancer survivors can reduce risk of recurrence

News

11/02/22

Women with a relative diagnosed by age 45 should consider early BC screening

09/04/17

Women with history of false-positive recall are at increased BC risk

10/14/11

High consumption of saturated fat linked to increased breast density

01/16/11

Patterns of BC in Black women suggest mammograms should start in 40s

01/04/11

Screening mammograms most accurate during week one of menstrual cycle

11/04/10

MRIs find additional disease in 20% of lobular BC patients

05/02/10

Reductions in breast density can reduce breast cancer risk

Studies

• The Relationship Between Breast Cancer Risk Factors and Mammographic Density Cite
  Ranjkesh M, Shaker S, Mehrtabar S, Ahmadpour Youshanlui M, Alihosseini S. The Relationship Between Breast Cancer Risk Factors and Mammographic Density. International Journal of Drug Research in Clinics. Maad Rayan Publishing Company; 2024; 2:e3 10.34172/ijdrc.2024.e3
• Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates Cite
  Monticciolo DL, Hendrick RE, Helvie MA. Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates. Radiology. Radiological Society of North America (RSNA); 2024; 310 10.1148/radiol.232658
• Breast cancer patients participating in the Swiss mammography screening program "donna" exhibit extended survival Cite
  Kuklinski D, Blum M, Subelack J, Geissler A, Eichenberger A, Morant R. Breast cancer patients participating in the Swiss mammography screening program "donna" exhibit extended survival. Research Square Platform LLC; 2024; 10.21203/rs.3.rs-3888314/v1
• Health benefits and harms of mammography screening in older women (75+ years)—a systematic review Cite
  Mathieu E, Noguchi N, Li T, Barratt AL, Hersch JK, De Bock GH, et al. Health benefits and harms of mammography screening in older women (75+ years)—a systematic review. British Journal of Cancer. Springer Science and Business Media LLC; 2023; 130:275-296 10.1038/s41416-023-02504-7
• Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors Cite
  Bhatt R, van den Hout A, Antoniou AC, Shah M, Ficorella L, Steggall E, et al. Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors. Cancer. Wiley; 2024; 10.1002/cncr.35183
• Beyond survival: a closer look at lead-time bias and disease-free intervals in mammography screening Cite
  Lee CI, Elmore JG. Beyond survival: a closer look at lead-time bias and disease-free intervals in mammography screening. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad254
• The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40–49 years: a modelling study Cite
  Huntley C, Torr B, Sud A, Houlston RS, Hingorani AD, Jones ME, et al. The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40–49 years: a modelling study. The Lancet. Elsevier BV; 2023; 402:S54 10.1016/s0140-6736(23)02103-7
• Breast Cancer Incidence After a False-Positive Mammography Result Cite
  Mao X, He W, Humphreys K, Eriksson M, Holowko N, Yang H, et al. Breast Cancer Incidence After a False-Positive Mammography Result. JAMA Oncology. American Medical Association (AMA); 2023; 10.1001/jamaoncol.2023.4519
• Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years Cite
  Wilkinson AN, Ellison LF, Billette J, Seely JM. Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 10.1200/jco.23.00348
• Clinical characteristics of interval breast cancer within 12 months and 13-24 months in Utah. Cite
  Wei M, Pappas L, Van Meter MEM, Freer P, Buys SS, Curtin K. Clinical characteristics of interval breast cancer within 12 months and 13-24 months in Utah.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:10531-10531 10.1200/jco.2023.41.16_suppl.10531
• Race and Ethnicity–Adjusted Age Recommendation for Initiating Breast Cancer Screening Cite
  Chen T, Kharazmi E, Fallah M. Race and Ethnicity–Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Network Open. American Medical Association (AMA); 2023; 6:e238893 10.1001/jamanetworkopen.2023.8893
• Invasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology Concordance Cite
  Pereslucha AM, Wenger DM, Morris MF, Aydi ZB. Invasive Lobular Carcinoma: A Review of Imaging Modalities with Special Focus on Pathology Concordance. Healthcare. MDPI AG; 2023; 11:746 10.3390/healthcare11050746
• Biomineralogical signatures of breast microcalcifications Cite
  Kunitake JA, Sudilovsky D, Johnson LM, Loh H, Choi S, Morris PG, et al. Biomineralogical signatures of breast microcalcifications. Science Advances. American Association for the Advancement of Science (AAAS); 2023; 9 10.1126/sciadv.ade3152
• Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study Cite
  Kou K, Cameron J, Youl P, Pyke C, Chambers S, Dunn J, et al. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study. Breast Cancer. Springer Science and Business Media LLC; 2023; 10.1007/s12282-023-01439-4
• Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis Cite
  Hussein H, Abbas E, Keshavarzi S, Fazelzad R, Bukhanov K, Kulkarni S, et al. Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis. Radiology. Radiological Society of North America (RSNA); 2023; 10.1148/radiol.221785
• Young Black Women May be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities Cite
  Wilkerson AD, Obi M, Ortega C, Sebikali-Potts A, Wei W, Pederson HJ, et al. Young Black Women May be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-022-12995-y
• Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography Cite
  Román M, Louro J, Posso M, Vidal C, Bargalló X, Vázquez I, et al. Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography. International Journal of Environmental Research and Public Health. MDPI AG; 2022; 19:2625 10.3390/ijerph19052625
• Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis Cite
  Durham DD, Abraham LA, Roberts MC, Khan CP, Smith RA, Kerlikowske K, et al. Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis. Cancer. Wiley; 2022; 10.1002/cncr.34365
• The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59 Cite
  Wilkinson AN, Billette J, Ellison LF, Killip MA, Islam N, Seely JM. The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59. Current Oncology. MDPI AG; 2022; 29:5627-5643 10.3390/curroncol29080444
• High risk breast cancer screening is a double edged sword: A qualitative study of patient perspectives on the Ontario High Risk Breast Cancer Screening Program Cite
  Deng SX, Castelo M, Reel E, Naganathan G, Eisen A, Muradali D, et al. High risk breast cancer screening is a double edged sword: A qualitative study of patient perspectives on the Ontario High Risk Breast Cancer Screening Program. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.08.004
• A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England Cite
  Blyuss O, Dibden A, Massat NJ, Parmar D, Cuzick J, Duffy SW, et al. A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England. Cancer Medicine. Wiley; 2022; 10.1002/cam4.5004
• Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review Cite
  Advani P, Advani S, Nayak P, VonVille HM, Diamond P, Burnett J, et al. Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2021; 16:514-530 10.1007/s11764-021-01046-2
• Cumulative risk of a false‐positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway Cite
  Tsuruda KM, Larsen M, Román M, Hofvind S. Cumulative risk of a false‐positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway. Cancer. Wiley; 2021; 128:1373-1380 10.1002/cncr.34078
• Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography Cite
  Ho TH, Bissell MCS, Kerlikowske K, Hubbard RA, Sprague BL, Lee CI, et al. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography. JAMA Network Open. American Medical Association (AMA); 2022; 5:e222440 10.1001/jamanetworkopen.2022.2440
• Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort Cite
  Ryser MD, Lange J, Inoue LY, O’Meara ES, Gard C, Miglioretti DL, et al. Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort. Annals of Internal Medicine. American College of Physicians; 2022; 10.7326/m21-3577
• Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) Cite
  Canelo-Aybar C, Posso M, Montero N, Solà I, Saz-Parkinson Z, Duffy SW, et al. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). British Journal of Cancer. Springer Science and Business Media LLC; 2021; 126:673-688 10.1038/s41416-021-01521-8
• Development and validation of a circulating microRNA panel for the early detection of breast cancer Cite
  Zou R, Loke SY, Tang YC, Too H, Zhou L, Lee ASG, et al. Development and validation of a circulating microRNA panel for the early detection of breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2022; 126:472-481 10.1038/s41416-021-01593-6
• Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer Cite
  Noguchi N, Marinovich ML, Wylie EJ, Lund HG, Houssami N. Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer. The Breast. Elsevier BV; 2022; 62:16-21 10.1016/j.breast.2022.01.015
• Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program Cite
  Blackmore KM, Chiarelli AM, Mirea L, Mittmann N, Muradali D, Rabeneck L, et al. Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program. Canadian Association of Radiologists Journal. SAGE Publications; 2022;:084653712110628 10.1177/08465371211062883
• Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling Cite
  Chapman CH, Schechter CB, Cadham CJ, Trentham-Dietz A, Gangnon RE, Jagsi R, et al. Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling. Annals of Internal Medicine. American College of Physicians; 2021; 10.7326/m20-6506
• Breast Cancer Screening Outcomes among Mexican-origin Hispanic Women Participating in a Breast Cancer Screening Program Cite
  Winters S, Alomari A, Shokar G, Martin C, Dwivedi A, Shokar NK. Breast Cancer Screening Outcomes among Mexican-origin Hispanic Women Participating in a Breast Cancer Screening Program. Preventive Medicine Reports. Elsevier BV; 2021;:101561 10.1016/j.pmedr.2021.101561
• Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women Cite
  Evans DG, Howell SJ, Gandhi A, van Veen EM, Woodward ER, Harvey J, et al. Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06333-1
• Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis Cite
  Alanko J, Tanner M, Vanninen R, Auvinen A, Isola J. Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 187:267-274 10.1007/s10549-020-06060-z
• Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram Cite
  McCarthy AM, Ehsan S, Appel S, Welch M, He W, Bahl M, et al. Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram. Cancer. Wiley; 2021; 10.1002/cncr.33661
• Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case-control study Cite
  Warner ET, Rice MS, Zeleznik OA, Fowler EE, Murthy D, Vachon CM, et al. Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case-control study. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00272-2
• Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History Cite
  van den Broek JJ, Schechter CB, van Ravesteyn NT, Janssens ACJW, Wolfson MC, Trentham-Dietz A, et al. Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 113:434-442 10.1093/jnci/djaa127
• Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study Cite
  Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, et al. Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study. Radiology. Radiological Society of North America (RSNA); 2021;:203935 10.1148/radiol.2021203935
• Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II Cite
  Gaudet MM, Deubler E, Diver WR, Puvanesarajah S, Patel AV, Gansler T, et al. Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06025-2
• Palpable Breast Findings in High-risk Patients: Are Self- and Clinical Breast Exams Worthwhile? Cite
  Portnow LH, D’Alessio D, Morris EA, Bernard-Davila B, Mango VL. Palpable Breast Findings in High-risk Patients: Are Self- and Clinical Breast Exams Worthwhile?. Journal of Breast Imaging. Oxford University Press (OUP); 2020; 10.1093/jbi/wbaa105
• Breast cancer distant recurrence lead time interval by detection method in an institutional cohort Cite
  Kaplan HG, Malmgren JA, Atwood MK. Breast cancer distant recurrence lead time interval by detection method in an institutional cohort. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-07609-3
• Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70–74 Years in Sweden Cite
  Mao Z, Nyström L, Jonsson H. Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70–74 Years in Sweden. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2149-2156 10.1158/1055-9965.epi-20-0523
• Presentation of self-detected breast mass in minority women with limited access to care: Can self-examination assist in early cancer detection? Cite
  Zhang Z, Rao R, Mango VL, Wilson-Gardner P, Vempalle S, Ojutiku O. Presentation of self-detected breast mass in minority women with limited access to care: Can self-examination assist in early cancer detection?. Clinical Imaging. Elsevier BV; 2020; 70:89-92 10.1016/j.clinimag.2020.10.032
• Disparities in Screening for Breast Cancer Based on Limited Language Proficiency. A Retrospective Cohort Propensity Score Matched Study Cite
  Cataneo JL, Raicu OA, Schwarzova K, Meidl H, Cruz C. Disparities in Screening for Breast Cancer Based on Limited Language Proficiency. A Retrospective Cohort Propensity Score Matched Study. Journal of the American College of Surgeons. Elsevier BV; 2020; 231:S36-S37 10.1016/j.jamcollsurg.2020.07.012
• Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience Cite
  Bennett I, Tourani S, Cockburn L, Reasbeck J, Grobbelaar N, Dann S, et al. Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience. ANZ Journal of Surgery. Wiley; 2020; 10.1111/ans.16320
• Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial Cite
  Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. The Lancet Oncology. Elsevier BV; 2020; 21:1165-1172 10.1016/s1470-2045(20)30398-3
• Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening Cite
  Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, Lång K, et al. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. Radiology. Radiological Society of North America (RSNA); 2020; 297:327-333 10.1148/radiol.2020201620
• Breast Cancer Screening Recommendations: African American Women Are at a Disadvantage Cite
  Rebner M, Pai VR. Breast Cancer Screening Recommendations: African American Women Are at a Disadvantage. Journal of Breast Imaging. Oxford University Press (OUP); 2020; 2:416-421 10.1093/jbi/wbaa067
• Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women Cite
  Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, et al. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer. Wiley; 2020; 126:2971-2979 10.1002/cncr.32859
• Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands Cite
  Lameijer JRC, Voogd AC, Pijnappel RM, Setz-Pels W, Broeders MJ, Tjan-Heijnen VCG, et al. Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands. British Journal of Cancer. Springer Science and Business Media LLC; 2020; 123:325-332 10.1038/s41416-020-0870-2
• Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts Cite
  Ezratty C, Vang S, Brown J, Margolies LR, Jandorf L, Lin JJ. Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:181-185 10.1007/s10549-020-05652-z
• Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years Cite
  García-Albéniz X, Hernán MA, Logan RW, Price M, Armstrong K, Hsu J. Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years. Annals of Internal Medicine. American College of Physicians; 2020; 172:381 10.7326/m18-1199
• Clinicopathologic update of calcium oxalate in breast: A 15‐year retrospective review Cite
  Haghayeghi K, Najibi M, Wang H, Donegan L, Wang Y. Clinicopathologic update of calcium oxalate in breast: A 15‐year retrospective review. The Breast Journal. Wiley; 2020; 26:1736-1741 10.1111/tbj.13952
• Abstract P4-17-08: Surveillance mammography after treatment for male breast cancer Cite
  Yadav S, Sangaralingham L, Payne SR, Giridhar KV, Hieken TJ, Boughey JC, et al. Abstract P4-17-08: Surveillance mammography after treatment for male breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p4-17-08
• Influence of breast density on breast cancer risk: a case control study in Japanese women Cite
  Nishiyama K, Taira N, Mizoo T, Kochi M, Ikeda H, Iwamoto T, et al. Influence of breast density on breast cancer risk: a case control study in Japanese women. Breast Cancer. Springer Science and Business Media LLC; 2019; 27:277-283 10.1007/s12282-019-01018-6
• Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women Cite
  Vande Walle K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, Fernandes-Taylor S, Schumacher JR, et al. Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:4310-4316 10.1245/s10434-019-07726-9
• Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Cite
  Gao Y, Goldberg JE, Young TK, Babb JS, Moy L, Heller SL. Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes. Radiology. Radiological Society of North America (RSNA); 2019; 293:282-291 10.1148/radiol.2019190971
• Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age Cite
  Demb J, Abraham L, Miglioretti DL, Sprague BL, O’Meara ES, Advani S, et al. Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2019; 112:599-606 10.1093/jnci/djz172
• Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study Cite
  Ha SM, Chae EY, Cha JH, Kim HH, Shin HJ, Choi WJ. Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study. European Radiology. Springer Science and Business Media LLC; 2019; 29:2526-2534 10.1007/s00330-018-5952-7
• Modifiable risk factors for advanced vs . early breast cancer in the French E3N cohort Cite
  Veron L, Gelot A, Gusto G, Arveux P, Delaloge S, Boutron‐Ruault M. Modifiable risk factors for advanced vs . early breast cancer in the French E3N cohort. International Journal of Cancer. Wiley; 2019; 146:850-860 10.1002/ijc.32354
• The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening Cite
  Tabár L, Dean PB, Chen TH, Yen AM, Chen SL, Fann JC, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. Wiley; 2018; 125:515-523 10.1002/cncr.31840
• Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts Cite
  Román M, Hofvind S, von Euler-Chelpin M, Castells X. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts. British Journal of Cancer. Springer Science and Business Media LLC; 2018; 120:269-275 10.1038/s41416-018-0358-5
• The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same? Cite
  Théberge I, Vandal N, Guertin M, Perron L. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 174:525-535 10.1007/s10549-018-05095-7
• Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers Cite
  Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, et al. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical Cancer Research. American Association for Cancer Research (AACR); 2018; 25:1786-1794 10.1158/1078-0432.ccr-18-0200
• Predictors of surveillance mammography outcomes in women with a personal history of breast cancer Cite
  Lowry KP, Braunstein LZ, Economopoulos KP, Salama L, Lehman CD, Gazelle GS, et al. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:209-215 10.1007/s10549-018-4808-9
• Breast density and breast cancer-specific survival by detection mode Cite
  van der Waal D, Verbeek ALM, Broeders MJM. Breast density and breast cancer-specific survival by detection mode. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4316-7
• Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography Cite
  van Bommel RM, Voogd AC, Nederend J, Setz-Pels W, Louwman MW, Strobbe LJ, et al. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography. The Breast. Elsevier BV; 2018; 38:101-106 10.1016/j.breast.2017.12.018
• Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics Cite
  Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, et al. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 170:129-141 10.1007/s10549-018-4735-9
• Breast Density and Risk of Invasive Breast Cancer among Older Women Undergoing Mammography: The Breast Cancer Surveillance Consortium Cohort Study Cite
  Braithwaite D, Miglioretti D, Zhu W, Demb J, Trentham-Dietz A, Sprague B, et al. Breast Density and Risk of Invasive Breast Cancer among Older Women Undergoing Mammography: The Breast Cancer Surveillance Consortium Cohort Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2018; 27:352.2-352 10.1158/1055-9965.epi-18-0044
• Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry Cite
  Jones T, Duquette D, Underhill M, Ming C, Mendelsohn-Victor KE, Anderson B, et al. Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:141-152 10.1007/s10549-018-4674-5
• Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR Cite
  Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. Journal of the American College of Radiology. Elsevier BV; 2018; 15:408-414 10.1016/j.jacr.2017.11.034
• Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cite
  Whitaker K, Guindalini R, Abe H, Sheeth D, Huo D, Hong S, et al. Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study. Poster Session Abstracts. American Association for Cancer Research; 2018; 10.1158/1538-7445.sabcs17-p4-02-10
• No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study Cite
  Lund E, Nakamura A, Thalabard J. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study. European Journal of Cancer. Elsevier BV; 2018; 89:102-112 10.1016/j.ejca.2017.11.003
• Breast cancer risk is increased in the years following false-positive breast cancer screening Cite
  Goossens MC, De Brabander I, De Greve J, Vaes E, Van Ongeval C, Van Herck K, et al. Breast cancer risk is increased in the years following false-positive breast cancer screening. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2017; 26:396-403 10.1097/cej.0000000000000313
• Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography Cite
  van Zelst JCM, Mus RDM, Woldringh G, Rutten MJCM, Bult P, Vreemann S, et al. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography. Radiology. Radiological Society of North America (RSNA); 2017; 285:376-388 10.1148/radiol.2017161218
• Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers Cite
  Krammer J, Pinker-Domenig K, Robson ME, Gönen M, Bernard-Davila B, Morris EA, et al. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:565-571 10.1007/s10549-017-4198-4
• Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review Cite
  Segnan N, Minozzi S, Armaroli P, Cinquini M, Bellisario C, González-Lorenzo M, et al. Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review. International Journal of Cancer. Wiley; 2016; 139:554-573 10.1002/ijc.30105
• The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations on Mammography Rates Cite
  Gray N, Picone G. The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations on Mammography Rates. Health Services Research. Wiley; 2016; 51:1533-1545 10.1111/1475-6773.12445
• No strong evidence for increased risk of breast cancer 8–26 years after multiple mammograms in their 30s in females at moderate and high familial risk Cite
  Evans DG, Kotre CJ, Harkness E, Wilson M, Maxwell AJ, Howell A. No strong evidence for increased risk of breast cancer 8–26 years after multiple mammograms in their 30s in females at moderate and high familial risk. The British Journal of Radiology. British Institute of Radiology; 2016; 89:20150960 10.1259/bjr.20150960
• Mammography Screening Among the Elderly: A Research Challenge Cite
  Sanderson M, Levine RS, Fadden MK, Kilbourne B, Pisu M, Cain V, et al. Mammography Screening Among the Elderly: A Research Challenge. The American Journal of Medicine. Elsevier BV; 2015; 128:1362.e7-1362.e14 10.1016/j.amjmed.2015.06.032
• Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement Cite
  Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. American College of Physicians; 2016; 164:279 10.7326/m15-2886
• Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial Cite
  Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. The Lancet Oncology. Elsevier BV; 2015; 16:1123-1132 10.1016/s1470-2045(15)00128-x
• Screening Mammography in a Public Hospital Serving Predominantly African-American Women: A Stage–Survival–Cost Model Cite
  Farley C, Friedman D, Habtes I, Raskind-Hood C, Adams EK, Becker ER, et al. Screening Mammography in a Public Hospital Serving Predominantly African-American Women: A Stage–Survival–Cost Model. Women's Health Issues. Elsevier BV; 2015; 25:322-330 10.1016/j.whi.2015.02.006
• Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis Cite
  van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EAM, Alagoz O, Trentham-Dietz A, et al. Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 107:djv103-djv103 10.1093/jnci/djv103
• Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50 Cite
  Winch CJ, Sherman KA, Boyages J. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 149:211-221 10.1007/s10549-014-3226-x
• Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients Cite
  Bick U. Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients. Breast Care. S. Karger AG; 2015; 10:13-20 10.1159/000375390
• Mammographic density and breast cancer risk by family history in women of white and Asian ancestry Cite
  Maskarinec G, Nakamura KL, Woolcott CG, Conroy SM, Byrne C, Nagata C, et al. Mammographic density and breast cancer risk by family history in women of white and Asian ancestry. Cancer Causes & Control. Springer Science and Business Media LLC; 2015; 26:621-626 10.1007/s10552-015-0551-2
• Symptomatic Breast Cancer Diagnosis and Multimodal Management in Women Aged 40 to 50 Years; Consequences of Current Mammographic Screening Programs Cite
  Joyce KM, McInerney NM, Waters PS, Sweeney KJ, Barry K, Kerin MJ. Symptomatic Breast Cancer Diagnosis and Multimodal Management in Women Aged 40 to 50 Years; Consequences of Current Mammographic Screening Programs. Clinical Breast Cancer. Elsevier BV; 2015; 15:e125-e130 10.1016/j.clbc.2014.11.001
• Symptomatic Breast Cancer Diagnosis and Multimodal Management in Women Aged 40 to 50 Years; Consequences of Current Mammographic Screening Programs Cite
  Joyce KM, McInerney NM, Waters PS, Sweeney KJ, Barry K, Kerin MJ. Symptomatic Breast Cancer Diagnosis and Multimodal Management in Women Aged 40 to 50 Years; Consequences of Current Mammographic Screening Programs. Clinical Breast Cancer. Elsevier BV; 2015; 15:e125-e130 10.1016/j.clbc.2014.11.001
• Increased risk of breast cancer in women with false-positive test: The role of misclassification Cite
  von Euler-Chelpin M, Kuchiki M, Vejborg I. Increased risk of breast cancer in women with false-positive test: The role of misclassification. Cancer Epidemiology. Elsevier BV; 2014; 38:619-622 10.1016/j.canep.2014.06.006
• What Factors Explain Disparities in Mammography Rates Among Asian-American Immigrant Women? A Population-Based Study in California Cite
  Ryu SY, Crespi CM, Maxwell AE. What Factors Explain Disparities in Mammography Rates Among Asian-American Immigrant Women? A Population-Based Study in California. Women's Health Issues. Elsevier BV; 2013; 23:e403-e410 10.1016/j.whi.2013.08.005
• Practices That Reduce the Latina Survival Disparity After Breast Cancer Cite
  Smith-Gagen J, Carrillo JE, Ang A, Pérez-Stable EJ. Practices That Reduce the Latina Survival Disparity After Breast Cancer. Journal of Women's Health. Mary Ann Liebert Inc; 2013; 22:938-946 10.1089/jwh.2012.4235
• Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study Cite
  Otten J, Fracheboud J, den Heeten G, Otto S, Holland R, de Koning H, et al. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. Annals of Oncology. Elsevier BV; 2013; 24:2501-2506 10.1093/annonc/mdt227
• Mammographic and ultrasound features of invasive lobular carcinoma of the breast Cite
  Porter AJ, Evans EB, Foxcroft LM, Simpson PT, Lakhani SR. Mammographic and ultrasound features of invasive lobular carcinoma of the breast. Journal of Medical Imaging and Radiation Oncology. Wiley; 2013; 58:1-10 10.1111/1754-9485.12080
• Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer Cite
  Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P. Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2013; 31:2249-2256 10.1200/jco.2012.44.5015
• Overdiagnosis in screening mammography in Denmark: population based cohort study Cite
  Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E. Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ. BMJ; 2013; 346:f1064-f1064 10.1136/bmj.f1064
• Mammographic Density and Estimation of Breast Cancer Risk in Intermediate Risk Population Cite
  Tesic V, Kolaric B, Znaor A, Kuna SK, Brkljacic B. Mammographic Density and Estimation of Breast Cancer Risk in Intermediate Risk Population. The Breast Journal. Wiley; 2012; 19:71-78 10.1111/tbj.12051
• Outcome of mammography in women with large breasts Cite
  Gayde C, Goolam I, Bangash HK, Tresham J, Fritschi L, Wylie E. Outcome of mammography in women with large breasts. The Breast. Elsevier BV; 2012; 21:493-498 10.1016/j.breast.2011.12.001
• Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses Cite
  Rakha EA, Lee AH, Reed J, Murphy A, El-Sayed M, Burrell H, et al. Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. European Journal of Cancer. Elsevier BV; 2010; 46:1835-1840 10.1016/j.ejca.2010.03.024
• Risk of Breast Cancer After False-Positive Test Results in Screening Mammography Cite
  von Euler-Chelpin M, Risor LM, Thorsted BL, Vejborg I. Risk of Breast Cancer After False-Positive Test Results in Screening Mammography. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:682-689 10.1093/jnci/djs176
• Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS Cite
  Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, et al. Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:614-621 10.1093/jnci/djs167
• The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- A review Cite
  Iwuchukwu O, Harvey J, Dordea M, Critchley A, Drew P. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- A review. Surgical Oncology. Elsevier BV; 2012; 21:133-141 10.1016/j.suronc.2011.01.002
• Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort Cite
  Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM. Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. British Journal of Cancer. Springer Science and Business Media LLC; 2012; 106:996-1003 10.1038/bjc.2012.1
• Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue Cite
  Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH. Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr3044
• Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study Cite
  Conroy SM, Pagano I, Kolonel LN, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study. Cancer Epidemiology. Elsevier BV; 2011; 35:448-452 10.1016/j.canep.2010.11.011
• Mammographic Density and Intake of Selected Nutrients and Vitamins in Norwegian Women Cite
  Qureshi SA, Couto E, Hilsen M, Hofvind S, Wu AH, Ursin G. Mammographic Density and Intake of Selected Nutrients and Vitamins in Norwegian Women. Nutrition and Cancer. Informa UK Limited; 2011; 63:1011-1020 10.1080/01635581.2011.605983
• Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics Cite
  Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, et al. Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:1179-1189 10.1093/jnci/djr225
• Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer Cite
  Houssami N. Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer. JAMA. American Medical Association (AMA); 2011; 305:790 10.1001/jama.2011.188
• Higher population-based incidence rates of triple-negative breast cancer among young African-American women Cite
  Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women. Cancer. Wiley; 2011; 117:2747-2753 10.1002/cncr.25862
• Accuracy of Screening Mammography Varies by Week of Menstrual Cycle Cite
  Miglioretti DL, Walker R, Weaver DL, Buist DSM, Taplin SH, Carney PA, et al. Accuracy of Screening Mammography Varies by Week of Menstrual Cycle. Radiology. Radiological Society of North America (RSNA); 2011; 258:372-379 10.1148/radiol.10100974
• Urinary cadmium and mammographic density in premenopausal women Cite
  Adams SV, Newcomb PA, Shafer MM, Atkinson C, Bowles EJA, Newton KM, et al. Urinary cadmium and mammographic density in premenopausal women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 128:837-844 10.1007/s10549-011-1383-8
• Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit Cite
  Cain H, Sinclair J, Martin A, Fasih T, Browell D, Clark K, et al. Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2680
• Prognosis and pathology of screen-detected carcinomas Cite
  Nagtegaal ID, Allgood PC, Duffy SW, Kearins O, Sullivan EO, Tappenden N, et al. Prognosis and pathology of screen-detected carcinomas. Cancer. Wiley; 2010; 117:1360-1368 10.1002/cncr.25613
• Abstract 5741: Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women's Health Initiative Cite
  Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Heiss G, et al. Abstract 5741: Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women's Health Initiative. Epidemiology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-5741
• Abstract 4828: Longitudinal breast density and risk of breast cancer Cite
  Vachon CM, Sellers TA, Scott CG, Ghosh K, Brandt KR, Olson JE, et al. Abstract 4828: Longitudinal breast density and risk of breast cancer. Epidemiology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-4828
• Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation Cite
  Chen J, Nie K, Bahri S, Hsu C, Hsu F, Shih H, et al. Decrease in Breast Density in the Contralateral Normal Breast of Patients Receiving Neoadjuvant Chemotherapy: MR Imaging Evaluation. Radiology. Radiological Society of North America (RSNA); 2010; 255:44-52 10.1148/radiol.09091090
• Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial Cite
  Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, et al. Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1450-1457 10.1200/jco.2009.23.0839
• 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis Cite
  Jansen-van der Weide M, Greuter M, Jansen L, Oosterwijk J, Pijnappel R, Oudkerk M, et al. 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:239 10.1016/s1359-6349(10)70642-x
• Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer Cite
  Tamimi RM, Colditz GA, Hankinson SE. Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer. Cancer Research. American Association for Cancer Research (AACR); 2009; 69:9323-9329 10.1158/0008-5472.can-09-1018
• Dietary intake and breast density in high-risk women: a cross-sectional study Cite
  Tseng M, Byrne C, Evers KA, Daly MB. Dietary intake and breast density in high-risk women: a cross-sectional study. Breast Cancer Research. Springer Science and Business Media LLC; 2007; 9 10.1186/bcr1781